Imunon Inc
IMNN
NASDAQ
Biotechnology
$1.65
USD
+0.07 (+4.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.81M
Volume 55.3K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-14.72M
TTM
+6.5%
YoY
Operating Cash Flow
$-15.11M
TTM
-5.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.5 | 1.6 | 1.8 | 2.0 | 1.3 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 2.8 | 3.5 | 4.3 | 4.3 | 2.8 |
Operating Income | -2.8 | -3.5 | -4.3 | -4.3 | -2.8 |
EBITDA | -2.7 | -3.4 | -4.2 | -4.2 | -2.7 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.1 | -0.0 |
Income Before Income Taxes | -2.7 | -3.4 | -4.2 | -4.2 | -2.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -2.7 | -3.4 | -4.2 | -4.2 | -2.8 |
Consolidated Net Income / Loss | -2.7 | -3.4 | -4.2 | -4.2 | -2.8 |
Net Income Attributable to Common Shareholders | -2.7 | -3.4 | -4.2 | -4.2 | -2.8 |
Basic EPS | -$2.15 | -$1.16 | -$1.42 | -$0.84 | -$0.54 |
Diluted EPS | -$2.15 | -$1.16 | -$1.42 | -$0.84 | -$0.54 |
Basic Shares Outstanding | 1.3M | 2.9M | 3.0M | 5.0M | 5.2M |
Diluted Shares Outstanding | 1.3M | 2.9M | 3.0M | 5.0M | 5.2M |